First independent validation of the proton-boron capture therapy concept
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61389005%3A_____%2F24%3A00598030" target="_blank" >RIV/61389005:_____/24:00598030 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/68407700:21340/24:00380584 RIV/00064190:_____/24:10001315
Výsledek na webu
<a href="https://doi.org/10.1038/s41598-024-69370-y" target="_blank" >https://doi.org/10.1038/s41598-024-69370-y</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1038/s41598-024-69370-y" target="_blank" >10.1038/s41598-024-69370-y</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
First independent validation of the proton-boron capture therapy concept
Popis výsledku v původním jazyce
Boron has been suggested to enhance the biological effectiveness of proton beams in the Bragg peak region via the p + 11B -> 3 alpha nuclear capture reaction. However, a number of groups have observed no such enhancement in vitro or questioned its proposed mechanism recently. To help elucidate this phenomenon, we irradiated DU145 prostate cancer or U-87 MG glioblastoma cells by clinical 190 MeV proton beams in plateau or Bragg peak regions with or without 10B or 11B isotopes added as sodium mercaptododecaborate (BSH). The results demonstrate that 11B but not 10B or other components of the BSH molecule enhance cell killing by proton beams. The enhancement occurs selectively in the Bragg peak region, is present for boron concentrations as low as 40 ppm, and is not due to secondary neutrons. The enhancement is likely initiated by proton-boron capture reactions producing three alpha particles, which are rare events occurring in a few cells only, and their effects are amplified by intercellular communication to a population-level response. The observed up to 2-3-fold reductions in survival levels upon the presence of boron for the studied prostate cancer or glioblastoma cells suggest promising clinical applications for these tumour types.
Název v anglickém jazyce
First independent validation of the proton-boron capture therapy concept
Popis výsledku anglicky
Boron has been suggested to enhance the biological effectiveness of proton beams in the Bragg peak region via the p + 11B -> 3 alpha nuclear capture reaction. However, a number of groups have observed no such enhancement in vitro or questioned its proposed mechanism recently. To help elucidate this phenomenon, we irradiated DU145 prostate cancer or U-87 MG glioblastoma cells by clinical 190 MeV proton beams in plateau or Bragg peak regions with or without 10B or 11B isotopes added as sodium mercaptododecaborate (BSH). The results demonstrate that 11B but not 10B or other components of the BSH molecule enhance cell killing by proton beams. The enhancement occurs selectively in the Bragg peak region, is present for boron concentrations as low as 40 ppm, and is not due to secondary neutrons. The enhancement is likely initiated by proton-boron capture reactions producing three alpha particles, which are rare events occurring in a few cells only, and their effects are amplified by intercellular communication to a population-level response. The observed up to 2-3-fold reductions in survival levels upon the presence of boron for the studied prostate cancer or glioblastoma cells suggest promising clinical applications for these tumour types.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30224 - Radiology, nuclear medicine and medical imaging
Návaznosti výsledku
Projekt
<a href="/cs/project/GA21-06451S" target="_blank" >GA21-06451S: Záhada zvýšení buněčné odezvy indukované protony v přítomnosti boru</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2024
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Scientific Reports
ISSN
2045-2322
e-ISSN
2045-2322
Svazek periodika
14
Číslo periodika v rámci svazku
1
Stát vydavatele periodika
DE - Spolková republika Německo
Počet stran výsledku
10
Strana od-do
19264
Kód UT WoS článku
001295308500085
EID výsledku v databázi Scopus
2-s2.0-85201637908